Royal DSM and Amyris have closed on a deal agreed in mid-November involving the sale of Amyris Brasil to DSM and setting up a long-term manufacturing partnership for Amyris’ high-volume products.
“Following our equity investment in Amyris and subsequent product development cooperations, I am pleased that we can add a state-of-the-art fermentation-based production facility to our network. Our know-how in fermentation, downstream process development and large-scale manufacturing will allow us to further improve the operational performance of the facility, while further strengthening our strategic alliance with Amyris,” said Chris Goppelsroader, President & CEO of DSM Nutritional Products.
“We are very pleased with the continued expansion of our strategic alliance with DSM,” added John Melo, Amyris President & CEO. “This manufacturing partnership and the sale of our Brotas 1 factory allows us to accelerate the development and manufacturing of specialty, high-performance ingredients.”